Anzalone Christopher Richard — SEC Form 4 filings

SEC reporting owner CIK 1423029. 13 Form 4 filings on record with FilingPulse; latest filed 2026-01-05.

Transaction summary — filings shown

Covers all 13 filings on record, filed 2024-02-02 to 2026-01-05. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)Chief Executive Officer, Director1340 legs · 961,083 sh · $34,486,27914

Form 4 filings — Anzalone Christopher Richard

FiledFormIssuerReported transactionsSource
2026-01-054ARROWHEAD PHARMACEUTICALS, INC. (ARWR)Sale (S): 7,416 @ $65.88 · Sale (S): 5,771 @ $66.39EDGAR
2025-12-304ARROWHEAD PHARMACEUTICALS, INC. (ARWR)Option exercise (M): 35,181 @ $6.15 · Option exercise (M): 16,545 @ $6.15 · Sale (S): 35,181 @ $69.33 · Sale (S): 16,545 @ $68.69 · Option exercise (M): 35,181 (derivative) @ $0 · Option exercise (M): 16,545 (derivative) @ $0EDGAR
2025-12-234ARROWHEAD PHARMACEUTICALS, INC. (ARWR)Sale (S): 3,979 @ $66.67 · Sale (S): 8,147 @ $68.01 · Sale (S): 1,319 @ $68.48 · Sale (S): 10,012 @ $68.33 · Sale (S): 2,574 @ $68.85EDGAR
2025-12-194ARROWHEAD PHARMACEUTICALS, INC. (ARWR)Sale (S): 46,287 @ $63.55 · Sale (S): 35,750 @ $64.51 · Sale (S): 982 @ $65.53 · Sale (S): 1,981 @ $66.30EDGAR
2025-12-164ARROWHEAD PHARMACEUTICALS, INC. (ARWR)Grant/award (A): 180,000 @ $0 · Sale (S): 100,532 @ $68.67 · Sale (S): 21,321 @ $69.28 · Sale (S): 8,147 @ $69.96 · Sale (S): 8,416 @ $60.51 · Sale (S): 10,963 @ $61.25 · +7 moreEDGAR
2025-04-114ARROWHEAD PHARMACEUTICALS, INC. (ARWR)Sale (S): 35,305 @ $9.93 · Sale (S): 3,400 @ $10.75 · Sale (S): 1,617 @ $11.76 · Sale (S): 50,000 @ $10.87 · Sale (S): 50,800 @ $11.49EDGAR
2025-03-174ARROWHEAD PHARMACEUTICALS, INC. (ARWR)Grant/award (A): 340,000 @ $0 · Sale (S): 51,425 @ $15.07EDGAR
2025-03-054ARROWHEAD PHARMACEUTICALS, INC. (ARWR)Option exercise (M): 166,667 @ $7.75 · Option exercise (M): 133,333 @ $7.75 · Sale (S): 166,667 @ $18.03 · Sale (S): 133,333 @ $17.02 · Option exercise (M): 166,667 (derivative) @ $0 · Option exercise (M): 133,333 (derivative) @ $0EDGAR
2025-02-104ARROWHEAD PHARMACEUTICALS, INC. (ARWR)Grant/award (A): 9,550 @ $20.10EDGAR
2025-01-064ARROWHEAD PHARMACEUTICALS, INC. (ARWR)Sale (S): 11,520 @ $19.05EDGAR
2024-12-234ARROWHEAD PHARMACEUTICALS, INC. (ARWR)Sale (S): 12,563 @ $19.59EDGAR
2024-12-204ARROWHEAD PHARMACEUTICALS, INC. (ARWR)Sale (S): 12,653 @ $20.52 · Sale (S): 8,260 @ $21.74 · Sale (S): 5,799 @ $22.12 · Grant/award (A): 100,000 @ $0EDGAR
2024-02-024ARROWHEAD PHARMACEUTICALS, INC. (ARWR)Option exercise (M): 57,499 @ $14.54 · Sale (S): 37,769 @ $32.16 · Sale (S): 19,730 @ $32.71 · Option exercise (M): 57,499 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1423029 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →